Proteus Biomedical has developed chip-in-a-pill technology that transmits patient data directly to a smartphone. Novartis has partnered with Proteus to investigate applications of this technology. C&EN senior editor Rick Mullin discusses how the nontraditional partnership is part of a larger trend.
Rick Mullin is a Senior Editor for Chemical & Engineering News. He’s based in Edison, New Jersey.